With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.125552-89-8,4-(Bromomethyl)tetrahydropyran,as a common compound, the synthetic route is as follows.
125552-89-8, 4-(Bromomethyl)tetrahydropyran (18 mg; 0.10 mmol) is added to 3-oxo-3,4-dihydro-2H-benzo[1,4]thiazine-7-sulfonic acid (4-ethylphenyl)isobutylamide (20 mg; 0.05 mmol) and cesium carbonate (24 mg; 0.07 mmol) dissolved in 1-methyl-2-pyrrolidone (0.4 ml). (0629) The reaction medium is heated at 80 C. for 24 hours, hydrolyzed and then extracted with ethyl acetate. The organic phases are combined, washed with brine and dried over sodium sulfate. (0630) The solvents are evaporated off and the crude product is chromatographed on silica gel (eluent: heptane/ethyl acetate, from 0 to 50% of ethyl acetate). (0631) The 3-oxo-4-(tetrahydropyran-4-ylmethyl)-3,4-dihydro-2H-benzo[1,4]thiazine-7-sulfonic acid (4-ethylphenyl)isobutylamide (10.4 mg; 40%) is obtained in the form of a beige-colored solid. (0632) 1H NMR (DMSO-d6) delta: 0.85 (d, J=6.8 Hz, 7H), 1.17 (t, J=7.6 Hz, 3H), 1.25 (d, J=6.5 Hz, 2H), 1.37-1.67 (m, 10H), 1.68-1.77 (m, 5H), 2.44 (dt, J=11.1, 4.0 Hz, 10H), 2.60 (q, J=7.6 Hz, 2H), 3.17 (s, 1H), 3.33-3.38 (m, 5H), 3.80 (dt, J=11.3, 3.7 Hz, 7H), 3.92 (s, 1H), 7.02 (d, J=7.8 Hz, 2H), 7.18 (dd, J=18.5, 8.4 Hz, 3H), 7.42 (d, J=8.4 Hz, 1H), 7.60 (d, J=2.1 Hz, 1H), 12.17 (s, 2H) (0633) MS: [M+H]=503
As the paragraph descriping shows that 125552-89-8 is playing an increasingly important role.
Reference£º
Patent; GALDERMA RESEARCH & DEVELOPMENT; MUSICKI, Branislav; BOUIX-PETER, Claire; OUVRY, Gilles; THOREAU, Etienne; (132 pag.)US2018/170869; (2018); A1;,
Tetrahydropyran – Wikipedia
Tetrahydropyran – an overview | ScienceDirect Topics